IL159981A0 - Direct binding assay for identifying inhibitors of hcv polymerase - Google Patents

Direct binding assay for identifying inhibitors of hcv polymerase

Info

Publication number
IL159981A0
IL159981A0 IL15998102A IL15998102A IL159981A0 IL 159981 A0 IL159981 A0 IL 159981A0 IL 15998102 A IL15998102 A IL 15998102A IL 15998102 A IL15998102 A IL 15998102A IL 159981 A0 IL159981 A0 IL 159981A0
Authority
IL
Israel
Prior art keywords
sup
sub
alkyl
hcv polymerase
het
Prior art date
Application number
IL15998102A
Other languages
English (en)
Original Assignee
Boehringer Ingelheim Ca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Ca Ltd filed Critical Boehringer Ingelheim Ca Ltd
Publication of IL159981A0 publication Critical patent/IL159981A0/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205—Phosphotransferases in general
    • G01N2333/91245—Nucleotidyltransferases (2.7.7)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Enzymes And Modification Thereof (AREA)
IL15998102A 2001-08-07 2002-08-05 Direct binding assay for identifying inhibitors of hcv polymerase IL159981A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31027201P 2001-08-07 2001-08-07
PCT/CA2002/001214 WO2003014377A2 (en) 2001-08-07 2002-08-05 Competitive binding assay for identifying inhibitors of hcv polymerase

Publications (1)

Publication Number Publication Date
IL159981A0 true IL159981A0 (en) 2004-06-20

Family

ID=23201740

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15998102A IL159981A0 (en) 2001-08-07 2002-08-05 Direct binding assay for identifying inhibitors of hcv polymerase

Country Status (13)

Country Link
US (1) US7294457B2 (da)
EP (1) EP1417493B1 (da)
JP (1) JP4646514B2 (da)
AT (1) ATE475095T1 (da)
CA (1) CA2450142C (da)
DE (1) DE60237089D1 (da)
DK (1) DK1417493T3 (da)
ES (1) ES2347954T3 (da)
HU (1) HUP0400670A3 (da)
IL (1) IL159981A0 (da)
MX (1) MXPA04001127A (da)
NZ (2) NZ554933A (da)
WO (1) WO2003014377A2 (da)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2335700A1 (en) * 2001-07-25 2011-06-22 Boehringer Ingelheim (Canada) Ltd. Hepatitis C virus polymerase inhibitors with a heterobicylic structure
GB0215293D0 (en) * 2002-07-03 2002-08-14 Rega Foundation Viral inhibitors
US7223785B2 (en) * 2003-01-22 2007-05-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
US7098231B2 (en) * 2003-01-22 2006-08-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
JP2006528685A (ja) 2003-05-06 2006-12-21 スミスクライン ビーチャム コーポレーション 新規化合物
AU2004261667A1 (en) 2003-08-01 2005-02-10 Genelabs Technologies, Inc. Bicyclic imidazol derivatives against Flaviviridae
USRE47600E1 (en) 2003-11-10 2019-09-10 STATS ChipPAC Pte. Ltd. Semiconductor device and method of forming electrical interconnect with stress relief void
US8026128B2 (en) 2004-11-10 2011-09-27 Stats Chippac, Ltd. Semiconductor device and method of self-confinement of conductive bump material during reflow without solder mask
US8216930B2 (en) 2006-12-14 2012-07-10 Stats Chippac, Ltd. Solder joint flip chip interconnection having relief structure
WO2005048311A2 (en) 2003-11-10 2005-05-26 Chippac, Inc. Bump-on-lead flip chip interconnection
US8129841B2 (en) 2006-12-14 2012-03-06 Stats Chippac, Ltd. Solder joint flip chip interconnection
US20060216860A1 (en) 2005-03-25 2006-09-28 Stats Chippac, Ltd. Flip chip interconnection having narrow interconnection sites on the substrate
US8574959B2 (en) 2003-11-10 2013-11-05 Stats Chippac, Ltd. Semiconductor device and method of forming bump-on-lead interconnection
US9029196B2 (en) 2003-11-10 2015-05-12 Stats Chippac, Ltd. Semiconductor device and method of self-confinement of conductive bump material during reflow without solder mask
WO2005049622A1 (ja) * 2003-11-19 2005-06-02 Japan Tobacco Inc. ５－５員縮合複素環化合物及びそのｈｃｖポリメラーゼ阻害剤としての用途
AU2004309390B2 (en) * 2003-12-22 2011-06-02 Gilead Sciences, Inc. Imidazo[4,5-c]pyridine compounds and methods of antiviral treatment
DK1718608T3 (da) * 2004-02-20 2013-10-14 Boehringer Ingelheim Int Virale polymeraseinhibitorer
US20070049593A1 (en) 2004-02-24 2007-03-01 Japan Tobacco Inc. Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
ATE428714T1 (de) * 2004-02-24 2009-05-15 Japan Tobacco Inc Kondensierte heterotetracyclische verbindungen und deren verwendung als hcv-polymerase-inhibitor
AU2005275181A1 (en) * 2004-07-14 2006-02-23 Ptc Therapeutics, Inc. Methods for treating hepatitis C
JP2008524335A (ja) * 2004-12-21 2008-07-10 ギリアド サイエンシズ， インコーポレイテッド イミダゾ［４，５−ｃ］ピリジン化合物および抗ウイルス処置法
US8703795B2 (en) 2005-03-02 2014-04-22 Fibrogen, Inc. Thienopyridine compounds, and methods of use thereof
US8841779B2 (en) 2005-03-25 2014-09-23 Stats Chippac, Ltd. Semiconductor device and method of forming high routing density BOL BONL and BONP interconnect sites on substrate
US8076365B2 (en) * 2005-08-12 2011-12-13 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
CN101374815B (zh) * 2006-01-27 2013-07-17 菲布罗根有限公司 使低氧诱导因子（hif）稳定的氰基异喹啉化合物
BRPI0710527B8 (pt) * 2006-04-04 2021-05-25 Fibrogen Inc compostos de pirrolo- e tiazolo-piridina e composição farmacêutica que os compreende
ES2339298T3 (es) * 2006-07-07 2010-05-18 Gilead Sciences, Inc. Compuesto de piridazina novedoso y uso del mismo.
UA99466C2 (en) 2007-07-06 2012-08-27 Гилиад Сайенсиз, Инк. Crystalline pyridazine compound
JP5649584B2 (ja) 2008-11-14 2015-01-07 フィブロジェン インコーポレイテッド Ｈｉｆヒドロキシラーゼ阻害剤としてのチオクロメン誘導体
PL2897939T3 (pl) 2012-09-21 2017-08-31 Sanofi Pochodne amidu kwasu benzoimidazolo-karboksylowego do leczenia chorób metabolicznych i sercowo-naczyniowych
RU2666144C2 (ru) 2013-01-24 2018-09-06 Фиброген, Инк. Кристаллические формы { [1-циано-5-(4-хлорофенокси)-4-гидроксиизохинолин-3-карбонил]-амино} -уксусной кислоты
JP6974331B2 (ja) 2016-02-05 2021-12-01 デナリ セラピューティクス インコーポレイテッドDenali Therapeutics Inc. 化合物、組成物及び方法
HUE058802T2 (hu) 2016-12-09 2022-09-28 Denali Therapeutics Inc RIPK1 inhibitorokként alkalmas vegyületek
EP4426434A1 (en) 2021-11-02 2024-09-11 Flare Therapeutics, Inc. Pparg inverse agonists and uses thereof
AU2023206890A1 (en) 2022-01-12 2024-08-22 Denali Therapeutics Inc. Crystalline forms of (s)-5-benzyl-n-(5-methyl-4-oxo-2, 3,4,5- tetrahydropyrido [3,2-b] [l,4]oxazepin-3-yl)-4h-l,2,4-triazole-3-carboxamide

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5316999A (en) * 1998-07-20 2000-02-07 Advanced Research And Technology Institute, Inc. Use of nucleic acid molecules as antiviral agents
JP2001069995A (ja) * 1999-07-02 2001-03-21 Japan Tobacco Inc 結晶構造解析に適したｈｃｖポリメラーゼ及びその利用方法
US6770666B2 (en) * 1999-12-27 2004-08-03 Japan Tobacco Inc. Fused-ring compounds and use thereof as drugs
ID30204A (id) 1999-12-27 2001-11-15 Japan Tobacco Inc Senyawa-senyawa cincin terfusi dan penggunaannya sebagai obat
US6448281B1 (en) 2000-07-06 2002-09-10 Boehringer Ingelheim (Canada) Ltd. Viral polymerase inhibitors
MXPA03007760A (es) 2001-03-08 2004-03-16 Boehringer Ingelheim Ca Ltd Analisis para identificar los inhibidores de la arn-polimerasa (ns5b) del hcv, dependiente del arn.
US6841566B2 (en) 2001-07-20 2005-01-11 Boehringer Ingelheim, Ltd. Viral polymerase inhibitors
EP2335700A1 (en) 2001-07-25 2011-06-22 Boehringer Ingelheim (Canada) Ltd. Hepatitis C virus polymerase inhibitors with a heterobicylic structure

Also Published As

Publication number Publication date
EP1417493B1 (en) 2010-07-21
NZ531488A (en) 2008-06-30
US20030108862A1 (en) 2003-06-12
US7294457B2 (en) 2007-11-13
DK1417493T3 (da) 2010-10-04
JP4646514B2 (ja) 2011-03-09
CA2450142A1 (en) 2003-02-20
ATE475095T1 (de) 2010-08-15
NZ554933A (en) 2009-01-31
WO2003014377A3 (en) 2003-12-18
CA2450142C (en) 2009-12-22
HUP0400670A2 (en) 2006-03-28
EP1417493A2 (en) 2004-05-12
JP2005500055A (ja) 2005-01-06
DE60237089D1 (de) 2010-09-02
ES2347954T3 (es) 2010-11-26
HUP0400670A3 (en) 2006-06-28
MXPA04001127A (es) 2004-07-08
WO2003014377A2 (en) 2003-02-20

Similar Documents

Publication Publication Date Title
IL159981A0 (en) Direct binding assay for identifying inhibitors of hcv polymerase
PT1414441E (pt) Inibidores da polimerase do vírus da hepatite c com estrutura heterobicíclica
EA200602170A1 (ru) Производные пиперидина, композиции на их основе, способы их применения
WO2006032466A3 (en) New bicyclic antibiotics
RS53599B1 (en) PIRIDON DERIVATIVES FOR STRESS MODULATION OF ACTIVATED PROTEIN KINASE SYSTEMS
WO2002088069A3 (en) Compounds useful as intermediates for 4-aminoquinoline derivatives
ATE350036T1 (de) Tetrahydroquinolin-derivate
ATE516321T2 (de) Zusammensetzungen mit fluorosubstituierten olefinen
TNSN04163A1 (fr) N-aryl-2-oxazolidinone-5-carboxamides et leurs derives et leur utilisation comme agents antibacteriens
DE60334524D1 (de) E2-verdrängungs-assay zur identifizierung von hpv-inhibitoren
AU7316900A (en) Compounds for fluorescence labeling
ATE342896T1 (de) Fluoreszierende proben zur quantitativen bestimmung von zink
DE50209786D1 (de) 7-aminotriazolopyrimidine zur bekämpfung von schadpilzen
CA2533685A1 (en) Nitrogen-containing fused heterocyclic carboxylic acid compounds
ATE411287T1 (de) Neue metallproteinaseinhibitoren
WO2003018549A3 (en) Bicyclic compounds as inhibitors of chemokine binding to us28
ATE236176T1 (de) Neue substrate zur detektion von mikrobiellen metaboliten
DE60014028D1 (de) Funktionalisierte verbindung, gegebenenfalls markierte polynukleotide und verfahren zur detektion einer ziel-nukleinsäure
ATE399168T1 (de) Imidazopyridin-derivate und ihre verwendung als induzierbare no-synthase inhibitoren
BRPI0415073A (pt) azaciclos n-substituìdos
BR0013075A (pt) Derivados de tetrazolinona
BRPI0417544A (pt) compostos quìmicos
BR0008589A (pt) Composto de tipirano, processo para sua preparação e seu uso
DK407882A (da) 2beta-substituerede 2alfa-methyl-5(r)penam-3alfa-carboxylsyre-1,1-dioxider og mellemprodukter herfor og deres fremstilling
ATE440100T1 (de) Prenyl transferasinhibitoren

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees